| Protein production and purification Architecture et Fonction des Macromolécules Biologiques Vincentelli Renaud 4 ... Nature methods 5 (2), 135-146, 2008 | 1006 | 2008 |
| Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease NR West, AN Hegazy, BMJ Owens, SJ Bullers, B Linggi, S Buonocore, ... Nature medicine 23 (5), 579-589, 2017 | 743 | 2017 |
| A versatile ligation-independent cloning method suitable for high-throughput expression screening applications NS Berrow, D Alderton, S Sainsbury, J Nettleship, R Assenberg, ... Nucleic acids research 35 (6), e45, 2007 | 654 | 2007 |
| Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature structural & molecular biology 27 (9), 846-854, 2020 | 517 | 2020 |
| Structure and functionality in flavivirus NS-proteins: perspectives for drug design M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard, S Cook, ... Antiviral research 87 (2), 125-148, 2010 | 448 | 2010 |
| Neutralization of SARS-CoV-2 by destruction of the prefusion spike J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ... Cell host & microbe 28 (3), 445-454. e6, 2020 | 392 | 2020 |
| Lysine methylation as a routine rescue strategy for protein crystallization TS Walter, C Meier, R Assenberg, KF Au, J Ren, A Verma, JE Nettleship, ... Structure 14 (11), 1617-1622, 2006 | 369 | 2006 |
| Glycoprotein structural genomics: solving the glycosylation problem VT Chang, M Crispin, AR Aricescu, DJ Harvey, JE Nettleship, JA Fennelly, ... Structure 15 (3), 267-273, 2007 | 353 | 2007 |
| CDR grafted anti-CEA antibodies and their production JR Adair, MW Bodmer, A Mountain, RJ Owens US Patent 5,877,293, 1999 | 306 | 1999 |
| The nsp9 replicase protein of SARS-coronavirus, structure and functional insights G Sutton, E Fry, L Carter, S Sainsbury, T Walter, J Nettleship, N Berrow, ... Structure 12 (2), 341-353, 2004 | 305 | 2004 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 304 | 2020 |
| A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization TS Walter, JM Diprose, CJ Mayo, C Siebold, MG Pickford, L Carter, ... Acta Crystallographica Section D: Biological Crystallography 61 (6), 651-657, 2005 | 293 | 2005 |
| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature communications 12 (1), 542, 2021 | 262 | 2021 |
| Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications C Tiede, AAS Tang, SE Deacon, U Mandal, JE Nettleship, RL Owen, ... Protein Engineering, Design & Selection 27 (5), 145-155, 2014 | 227 | 2014 |
| Affimer proteins are versatile and renewable affinity reagents C Tiede, R Bedford, SJ Heseltine, G Smith, I Wijetunga, R Ross, ... Elife 6, e24903, 2017 | 219 | 2017 |
| The crystal structure of IgE Fc reveals an asymmetrically bent conformation T Wan, RL Beavil, SM Fabiane, AJ Beavil, MK Sohi, M Keown, RJ Young, ... Nature immunology 3 (7), 681-686, 2002 | 213 | 2002 |
| Recombinant protein expression and solubility screening in Escherichia coli: a comparative study NS Berrow, K Büssow, B Coutard, J Diprose, M Ekberg, GE Folkers, ... Acta Crystallographica Section D: Biological Crystallography 62 (10), 1218-1226, 2006 | 207 | 2006 |
| Structural and functional insights of RANKL–RANK interaction and signaling C Liu, TS Walter, P Huang, S Zhang, X Zhu, Y Wu, LR Wedderburn, ... The Journal of Immunology 184 (12), 6910-6919, 2010 | 198 | 2010 |
| Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication R Assenberg, E Mastrangelo, TS Walter, A Verma, M Milani, RJ Owens, ... Journal of virology 83 (24), 12895-12906, 2009 | 190 | 2009 |
| Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules MW Bodmer, JR Adair, NR Whittle, AH Lyons, RJ Owens US Patent 5,219,996, 1993 | 185 | 1993 |